Dr. Esther Cynn is a patent agent in the New York office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Her background includes genetics, cardiometabolic diseases, human nutrition, cellular and molecular biology. Esther applies her experience to patent prosecution, freedom-to-operate, and due diligence matters for clients in the life sciences, pharmaceutical, biotechnology, diagnostics, and medical devices industries.
Prior to joining the firm, Esther completed her doctorate degree at Columbia University. Her dissertation focused on understanding the function and mechanism of a macrophage-specific human long noncoding RNA, in the context of cardiovascular disease.
Dr. Esther Cynn is a patent agent in the New York office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Her background includes genetics, cardiometabolic diseases, human nutrition, cellular and molecular biology. Esther applies her experience to patent prosecution, freedom-to-operate, and due diligence matters for clients in the life sciences, pharmaceutical, biotechnology, diagnostics, and medical devices industries.
Prior to joining the firm, Esther completed her doctorate degree at Columbia University. Her dissertation focused on understanding the function and mechanism of a macrophage-specific human long noncoding RNA, in the context of cardiovascular disease.
- Ph.D., Nutritional and Metabolic Biology, Columbia University, 2022
- M.S., Human Nutrition, Columbia University, 2015
- B.S., Double Major in Chemistry and Biological Sciences, Cornell University, 2014
- U.S. Patent and Trademark Office
- Ph.D., Nutritional and Metabolic Biology, Columbia University, 2022
- M.S., Human Nutrition, Columbia University, 2015
- B.S., Double Major in Chemistry and Biological Sciences, Cornell University, 2014
- U.S. Patent and Trademark Office
Select Publications
- Co-author with T Cao, O’Reilly ME, et al., “Cis-regulated expression of Non-conserved LincRNAs Associates with Cardiometabolic Related Traits,” J Hum Genet, May 2022
- Co-author with AS Foulkes, C Selvaggi, et al., “Nonconserved Long Intergenic Noncoding RNAs Associate with Complex Cardiometabolic Disease Traits,” Arterioscler Thromb Vasc Biol, January 2021
Select Publications
- Co-author with T Cao, O’Reilly ME, et al., “Cis-regulated expression of Non-conserved LincRNAs Associates with Cardiometabolic Related Traits,” J Hum Genet, May 2022
- Co-author with AS Foulkes, C Selvaggi, et al., “Nonconserved Long Intergenic Noncoding RNAs Associate with Complex Cardiometabolic Disease Traits,” Arterioscler Thromb Vasc Biol, January 2021
Biological Sciences and Biotechnology
- Cell biology
- Cellular biology
- Immunobiology
- Microbiology
- Molecular biology
Therapeutics and Drug Discovery
- Gene editing
Biological Sciences and Biotechnology
- Cell biology
- Cellular biology
- Immunobiology
- Microbiology
- Molecular biology
Therapeutics and Drug Discovery
- Gene editing
Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the offering. The Wilson Sonsini team included Lou Lieto, Clark Lin, Rachna Ujwal, and Esther Cynn.
- Privacy Policy
- Terms of Use
- Accessibility